From C-Suite to VC: Lessons from the Biotech Trenches

This panel of top-tier biotech CEOs turned VC investors and advisors, will discuss their outlook on the financing market, and share key lessons as they grew and built their companies to multi-billion dollar valuations. The panel features former CEOs and C-level executives from some of the industry's largest, most prominent biotechs, who have moved to VC. Hear about their journey, and this panel will bring a unique perspective from former pharma execs turned VC.